Robert E. Mansel
About
In The Last Decade
Robert E. Mansel
173 papers receiving 9.3k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Cancer Research 4.4k
- Oncology 3.4k
- Pathology and Forensic Medicine 2.9k
- Molecular Biology 2.5k
- Surgery 2.2k
Countries citing papers authored by Robert E. Mansel
This map shows the geographic impact of Robert E. Mansel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Mansel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Mansel more than expected).
Fields of papers citing papers by Robert E. Mansel
This network shows the impact of papers produced by Robert E. Mansel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Mansel. The network helps show where Robert E. Mansel may publish in the future.
Co-authorship network of co-authors of Robert E. Mansel
This figure shows the co-authorship network connecting the top 25 collaborators of Robert E. Mansel. A scholar is included among the top collaborators of Robert E. Mansel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert E. Mansel. Robert E. Mansel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 46 | |
| 2 | 12 | |
| 3 | 5 | |
| 4 | 6 | |
| 5 | The aberrant expression of bone morphogenetic protein 12 (BMP-12) in human breast cancer and its potential prognostic value | 3 |
| 6 | 32 | |
| 7 | 22 | |
| 8 | [Expression of placental growth factor and pigment epithelium-derived factor in non-small cell lung cancer and the prognostic significance thereof]. | 2 |
| 9 | The effects of interleukin-7 on the lymphangiogenic properties of human endothelial cells. | 40 |
| 10 | The potential lymphangiogenic effects of hepatocyte growth factor/scatter factor in vitro and in vivo. | 36 |
| 11 | 22 | |
| 12 | 74 | |
| 13 | 49 | |
| 14 | 202 | |
| 15 | 95 | |
| 16 | 38 | |
| 17 | Hepatocyte growth factor modulates vascular endothelial-cadherin expression in human endothelial cells. | 26 |
| 18 | The presentation and management of breast symptoms in general practice in South Wales. The BRIDGE Study Group. | 14 |
| 19 | 13 | |
| 20 | 49 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.